drugset / Trial / NCT01402713

To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children

NCT01402713

Phase 2/3 Completed 311 enrolled Green Cross Corporation
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to evaluate the effectiveness(immunogenicity) and safety of 'GC1107' administered intramuscularly in healthy children

Timeline

Start
2011-08
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject GC1107 Unknown 0.5 ml Intramuscular
Comparator SK Td vaccine Vaccine 0.5 ml
Comparator TD_PUR INJ Unknown 0.5 ml